Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2006, p. 3448-3451, Vol. 44, No. 9
0095-1137/06/$08.00+0 doi:10.1128/JCM.01433-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
awa Dubaniewicz-Wybieralska,2
Adam Sternau,3
Zofia Zwolska,4
Ewa I
ycka-
wieszewska,5
Ewa Augustynowicz-Kope
,4
Jaros
aw Skokowski,6
Mahavir Singh,7 and
Lech Zimnoch8
Department of Pathophysiology, Medical University of Gdansk, Gdansk, Poland,1 Department of Radiology, Medical University of Gdansk, Gdansk, Poland,2 Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland,3 National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland,4 Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland,5 Department of Surgical Oncology, Medical University of Gdansk, Gdansk, Poland,6 LIONEX Diagnostics and Therapeutics GmbH and GBF, Braunschweig, Germany,7 Department of Medical Pathomorphology, Medical University of Bialystok, Bialystok, Poland8
Received 11 July 2006/ Accepted 14 July 2006
We demonstrated that not whole Mycobacterium tuberculosis but its particular antigens, hsp70Mtb, hsp65Mtb, and hsp16Mtb, are present in lymph node tissues of patients with sarcoidosis (SA). hsp16Mtb occurs in the early stage of SA, whereas hsp70Mtb occurs in stage II of SA. hsp65Mtb is highly expressed in the capillary vessels in lymph node tissues in patients with SA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»